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Radiation on Mast Cells: PUV A Suppresses Degranulation of Mouse 
Skin Mast Cells Induced by Compound 48/80 or Concanavalin A 
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In order to see whether 8 -methoxypsoralen (8-MOP) 
plus long-wave ultraviolet (UV A) radiation (PUVA) has 
an influence on immediate-type skin reactions, we have 
undertake n a n animal study. Ears of mice were treated 
with a 0 .5 % 8-MOP solution topically plus UV A radia-
tion (1.5-2.5 J /cm 2 ). After PUVA radiation, skin re-
sponses to intradermal injection with mast cell libera-
tors, including compound 48/80 (2.5 mg/ml, 10 J.Ll) and 
concanavalin A (Con-A) (2 .0 mg/ml), or with a mixture 
of 5-hydroxytryptamine (5-HT) and his tamine as vaso-
dilator (1.0 mg/ml and 50 mM, r espectively) were ex-
amined with time (2 h-1 4 days). At each time point, an 
ear swelling r esponse (ESR) was measured with a dial 
thickness gauge. The rate of mast cell degr a nulation and 
mast cell numbers were asssessed by light microscopy 
using toluidine blue-stained semithin (1 J.Lm) sections. 
ESR induced by compound 48/80 or Con-A was signifi-
cantly suppressed dose -depende ntly (>4 2 % inhibition) 
by PUV A between 2 h-3 days pos tirradiation as com-
pared with that in nonirradiated control mice, and the 
value r e turned to normal levels by 7-14 days. Com-
pound 48/80- or Con-A-induced mast cell degranulation 
(%) was r e markably decreased be tween 2 h-3 days 
(>48% inhibition) in accordance with the suppression in 
ESR a nd it was r estor ed to the rates in nonirradiated 
controls b y 7-14 days. Neither ESR nor percent degran-
ulation was affected b y UVA radiation only (<3.5 Jjcm2 ) 
or application of 8-MOP only. 5-HT plus histamine-
mediated ESR was not. a ltered at all by PUV A through-
out the experimenta l period. Since PUV A radiation it-
self at given doses did not produce measurable ESR, 
mast cell degranula tion, or a reduction in mas t cell 
numbers, and s ince PUV A did not affect a normal vas-
cular r esponse to vasodilato1·, it seemed that decreased 
skin r eactivity to mast cell degranulators by PUV A 
might be due to a PUV A-induced noncytolytic alteration 
in mast cell r e lease mechanisms. 
8- Methoxypsora len (8-MOP) p lus long-wave ul tr av iolet 
(UV A) radiat ion (PUV A) has been successfully used in t he 
treaLment o f so me cases o f so lar urticari a a nd cuta neous a nd 
systemic mastocytosis [1 -3]. Reli ef of itchin g a nd whealing is 
obta ined by repeated PUV A t reatments. Mast cells p lay a key 
role in t he pathoge nes is of t hose diseases: t hey synthesize a nd 
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Abbreviations: 
Con-A: co ncanavalin A 
ESR: ea r ~well ing respo nse 
5- HT: 5- hydroxyt ryptam ine 
8- MOP: 8-met hoxypsoralen 
PUVA: 8-MOP plus UVA rad iation 
UVA: long-wave ultraviolel (:120- 400 nrn ) 
re lease biologically active products, including vasoactive 
amines, chemotactic mediators, prostagla ndins, a nd proteolytic 
enzymes, t hat a re responsible in part for disabling symptom 
such as pruritus , flu shin g, a nd whealin g [4]. However, the 
underly ing mecha nisms fo r t he beneficial effect of t his new 
t herapy a re still debatable. Clinical studies wit h various resul ts 
have been repo rted: PUV A ra di a tion e it her decreases or has no 
effect on mast cell numbers, mast ce ll degranulation induced 
by compound 48/80, skin histamine contents, a nd va cular 
respo nsiveness to his tamine [2,3,5-7]. H owever, t here have 
appare nt iy been no basic studies investigating t he effect of 
PUV A on mast cell function s . 
In t hi s study, m ouse ear skin was irradiated wi t h PUVA and 
t he e ffec t of PUV A on skin reac t ivity to compound 48/80, 
concanavalin A (Con-A), or 5-hydroxytrypta mine (5-HT) plus 
histamine was examined at various t ime intervals after P UVA 
radiation . W e assessed a n ear swelling resp onse (ESR) , rate of 
mast cell degranulation , an d mast cell numbers by measuring 
ear t hickness a nd by light microscopy, respectively. 
MATERIALS AND METHODS 
Animals 
Six-week-old BALB/c female mice (body weight: approx imately 25 
g) we re used. 
U yht Source 
As a UV A light source we used an instrument with 10 tubes of 20-
W lluorescent blacklight (Tos hiba FL 205 BLB). This blackligh t bulb 
emits rays between :300- 400 nm, peaking at 360 nm (mainly UVA). 
The tota l irrad iance of this instrument measured at a target distance 
of 30 em through a 2 mm-thick glass filter was 4.0 m W /cm2 in the 
range of 310- 400 nm (peak 365 nm) and 0.03 m W /cm2 in the range of 
270- 330 nm (peak 305 nm ). The irradiance was measured with the aid 
of a UV radiometer (Model UVR 305/365, Toshiba Medical Supplies. 
Tokyo, ,Japan). 
PUVA Radiation 
A 1% 8- MOP solu tion was obtained commercially from Taisho 
Pharmaceutical Company (Tokyo, J apan), and was diluted to a final 
concentra t ion of 0.5% with 99% ethanol. One hour after a 0.5% -
MOP solu tion was applied to both ventra l and dorsa l surfaces of mouse 
ears (20 J.d per ear), mice were exposed t.o a UVA radiation, being kept 
in a cage (maximum 10 mice per cage) placed under the light. The cage. 
30 em (width) X 25 em (length) X 2 em (height) in size, was covered 
by a thin wire network (Nakagawa Medica l P roduct Supplies, Kyoto, 
J apan), so that during t he exposure mice could move freely without 
lying one over another. UV radiation was evenly distributed over the 
area of the cage (±5% in an error range in irradiance). A single 
administration or PUVA was carried ouL wi th a tota l energy dose 
rangin g from 1.5- 3.5 J /cm2 (irradiation ti me: approxim ately 6- 15 min). 
llO 
Chemicals 
Compou nd 48/80 and Con-A (S igma Chemical Company, St. Louis. 
Missouri) were used as mast cell degranulators. 5- HT plus histamine 
(Wako Pure Chemical Industries, Osaka, Japan) was used as vasoili-
lalor because in mice 5-HT is much more pote nt than histamine in its 
abi lity to increase vascular permeabili ty, a lthough mouse mast cells 
conta in both 5-HT and histamine [8]. Ten microli ters of compound 
48/80 (2.5 mg/ml), Con-A (2.0 mg/ml) , or a mixture of 5-HT and 
hista mine ( 1.0 mg/ml and 50 mM , respectively) were fresh ly dissolved 
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in physio logic saline and were injec ted intrade rmally into the dorsa l 
aspect of a mouse ea r using a mi crosy rin ge (Type 705RN , Hamilton. 
Reno, Nevada) with a 28-gauge hypodermi c needle (Type N·728, Ham-
ilton). The concentrations of the chemica ls were determined accordin g 
to t h e methods of .J ames eta! 191 (compound 48/80 and fi- HT) and by 
our preliminary studies (Co n-A and hi stamine). All three reagents 
produced measurable ESR and also, in the case of compou nd 48/80 
and Co n·A , ESR was accompanied h~' a moderate mast cell response. 
Ea r .Swellin~t RPsponsf' 
Thickness of ea rs was measured with a dial thickness gauge (Pea -
cock , Tokyo, .Japan) under mild anesthesia with pent obarbital sodium 
(40 mg/kg). ESR represented an increment in thick ness above baseline 
control values. ESR was determined 30- 45 min aft er a chemica l injec-
tio n . The va lue seemed to rep resent effect of the chemical itself but 
not a n amou nt of the medium injected (physica l swelling) because 
within such t ime inte rvals ESR evoked by ph.vs iologic sa line returned 
nea r ly to the baseline thickness. 
Mast Cell Degranulation and Numbers 
After ESR was measured, chemica l-injected ea rs were removed and 
cut into small pieces. Samples were immediate ly immersed in a fix ative 
con ta ining 2t;;. paraformaldehyde, 2.5% glu ta ra l deh~·de , and 0.025% 
CaC I2 in 0.1 M cacodylate buffer, pH 7.4 [10], and were kept at room 
tempe rat ure for [) h. Tissue processing was carried out according to the 
meth od desc ribed by Eady et a! I I 11 . Semithin sect ions (1 i.lm t hick) 
were sta in ed with 0.05% toluidine blue and mou nt ed in immersion oil 
fo r li ght microscopic studies. 
Mast cells were identified by their c,,·top lasmic granul es showing 
metachromasia. Mast ce ll numbers were coun ted in a- 5 tissue ~ections 
from each ea r sa mple, while at the sa me Lime fhe tota l length of 
sections was measured by using a sca le (0. 1 mm in length) in serted in 
the ocular (I Ox) . Mast cell counts were divided by the numbe r of sca les 
p rojected into sections examined and the value represe nt ed the number 
of mast ce ll s per linea r millimeter of section. Degranulation was co n-
s ide red to have occurred when free granules could be observed a round 
the cells [91 (Fig l ) and percent of degranulat ion was read . 
Experimental Protocol 
G roups of mice were irradiated with a ingle PUVA rad iat ion ( !.5 or 
2 .. 5 J /cm") and the ea rs of treated mice we re injected with compound 
48/ 80, Con-A, or 5-1-IT/ histamine at /on 2 h, 3, 7, and 14 days postir-
radiation. We used 5 mice ( LO ear samples) per chemical per irradiation 
dose. At each t ime point 5 noni rradiated mice were treated similarly. 
No more tha n one injection was give n to the same mouse. Co nt rols 
also included a similar number of mice per chemical that· received either 
UVA radiation only (1.5 J /cm2 ) or application of 0.5 °(; 8- MOP only. 
P rior to these ex periments a sepa rate group of 20 mice was ex posed to 
PUV A radiation with va ri ous doses ( 1.5- 3.5 J /cm2 ) to determi ne the 
effect of PUVA on ESR and mast cell responses with time. 
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F I G 1. A toluidi ne blue-sta ined mouse ea r semi lhin (1 !.l thick) 
sectio n, showing compound 48/80-mediated mast ce ll degranulat ion 
(thic l? arrow). Note secretory granules are dispersed around the cell. 
Thin arrows indica te in tact mas t cells that are packed with dense 
granu les. X 1300. 
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S tatist ical Evaluation 
For statistical evaluation , Student's t-test was applied between a 
pair of values (mean ± 1 SO) : the va lue in a PUVA-treated group was 
co mpared with that in a nonirradiated co ntrol group. 
RESULTS 
Effects of PUVA Radiation on Mouse Ear Shin 
Effects of PUV A on mouse ears were examined at/on 2 h , 3, 
7, 14, a nd 28 days posti rradiation . PUV A radiation at the lower 
doses (<2.5 J /cm2) produced no significa n t ESR for t he obser-
vation period (max imum 3.18 ± 0.94 X 10- 2 mm on day 3), 
while distribution of more energy doses (3 .5 J / cm2 ) caused 
remarkable ESR with its peak on day 3 (33.75 ± 4.60 x 10- 2 
mm ). Swollen ea rs returned nearly to normal baseline th ickness 
by 21 days. H owever , apparent mast cell degranulation was not 
observed within t he given dose ra nge (1.5-3.5 J /cm 2 ) over a 28-
day period. Nor were mast cell counts significan t ly altered 
(6.43- 7.00/ mm) as compared with t he m ean value obtained 
from 10 normal mice (6.49 ± 1.44/ mm) . 
Other histologic findings showed t hat within irradiation 
doses o f 1.5-2.5 J / cm2 there were no remarkable epidermal or 
dermal changes in mouse ear sections over a 28-day period. By 
irradiation with 3.5 J / cm2 dermal edema with a few mononu-
clear cell infilt rates was noticed on day 3 but t here was n o 
appa ren t acan thosis or hyperkeratosis by t his t ime point. Mi ld 
acanthosis and hyperke ratos is occurred by day 7 a nd t he degree 
of such epidermal changes became maximum by day 14, while 
dermal edema was regressing gradually. There was no ep idermal 
cell nec rosis that resembled sunburn ce lls. The number of 
dermal cell infil t rates rema ined few. These hi stologic findings 
faded by 28 day posti rradiat ion . 
In t he following experiments, the effect of PUV A on mast 
cells was examined in mice receiving only PUV A radiation 
doses t hat caused negligible ESR (1.5 and 2.5 J / cm2 ) in orde r 
to exclude t he possibility that PUV A-induced inflammatory 
reactions exert a nonspecific influence upon t he degree of skin 
reactivi ty to liberators. 
Injection with Compound 48/80 in PUVA -Treated Mice 
ln P U V A-irradiated mice, compound 48/80-induced ESR (x 
w-~ mm) were significant ly suppressed in a PUV A dose-de-
pendent manner at 2 h posti rradiation (6.74 ± 1.48, 1.5 J / cm2 ; 
5.25 ± 1.09, 2.5 J/cm~ ) as compared with the value in nonirra-
diated mice (9.27 ± 1.89) (Fig 2). The value in nonirradiated 
mice was t he mean of those obta ined over a 14-day period (and 
so forth) . Decreased ESR were obse rved on days 3-7 (5.38 ± 
1.87, 1.5 J jcm2 ; 4.90 ± 2.67, 2.5 J /cm2 on day 3) and were 
restored to normal levels by day 14. Percent mast cell degran -
ulation was a lso s ignifica nt ly decreased at 2 h in accordance 
with t he suppression in ESR. A dose-dependent decrease in 
percen t degranulat ion occurred most remarkably on day 3 
(15.64 ± 8.86, 1.5 J / cm2; 5.78 ± 5.23, 2.5 J / cm 2) as compared 
with that in nonirradiated mice (30.00 ± 5.78). The decreased 
ra te of degranu lation partially recovered on day 7 (recovery 
appeared to be slower in t he group with higher-dose irradiation) 
and was restored to normal levels by day 14 (Fig 3). Mast ce ll 
numbersjmm were not s ignificantly changed by injection wi t h 
compound 48/80 in PUVA-irradiated mice over a period of 2 
h- 14 days (5.79- 6.86, 1.5 J / cm2; 5.99- 7.14, 2.5 J / cm2 ) as com-
pared with t hose in nonirradiated , compound 48/80-treated 
mice (6.66 ± 1.17). The latter figure was not different statisti-
cally from norm al mast cell densi ty in t his stra in of mice (see 
under "PUVA Radiation"). Either irradiation with UVA on ly 
or a topica l app licat ion of 8 -MOP only did not significantly 
decrease compound 48/ 80- induced ESR or percent mast cell 
degra nulation, nor a lter mast ce ll numbers (data on 8-MOP 
only not shown in Figs 2 a nd 3). 
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2~R 1 14 DAY S 
T IME INTERVALS AF T ER PUVA RADIATION 
F1r. 2. Compound 48/80- induced ear swelling response in PUVA-
treatecl mi ce. Ten microli te rs of compound 48/80 (2.5 mg/ml) was 
injected in t.o PUVA-irradiated or nonirrad iated (control) mouse ea rs 
at. several time in te rvals afte r a single PUVA irradiation , and ESR 
above the baseline thi ckness was measured. Each group co nsisted of 5 
mice (10 ea r sa mples) . Each value (mean ± 1 SD) of treated mice was 
compared with th at of the nonirrad iated, compou nd 48/80- injected 
group (the value of co ntrols was t he mea n of those ohtained over a 14 -
day period). No significa nt effects were obse rved with UVA rad i.ation 
only or with 8-MOP painting only (the latte r data not shown). 
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T IME INTERVAL S AFTER PUVA RAD IATION 
F IG 8. Compound 48/80- induced mast ce ll degranul ation in PUVA-
treated mice. Ten microliters of compound 48/80 (2.5 mg/ml ) was 
injected int o P UVA -irradiated or nonirradiated (control) mouse ears 
at several time int erva ls afte r a sin gle PUVA irradiation and percent 
of degranulated cells was coun ted. Each group consisted of 5 mice (lO 
ear samples ). Each value (mean± 1 SD) of treated mice was compared 
with t hat of the nonirradiated, compou nd 48/80-injected group (the 
value of controls was the mean of those obtained over a 14 -day period) . 
No significant effects were obse rved with UV A radiation only or with 
8-MOP paint in g only (the la tter data not shown). 
injection with Con-A in P UVA -Treated Mice 
By PUVA radiation, Co n-A -induced ESR (x 10- 1 mm) were 
s ignificant ly suppressed (6.00 ± 0.58, 1.5 J/cm2 ; 5.40 ± 1.96, 
2.5 J/cm2 ) at 2 h postirradiation as compared with t hose in 
nonirradiated mice (11.52 ± 2.34). Con-A- induced ESR co ntin-
ued to be suppressed on day 3 (4.22 ± 1.72, 1.5 J/cm 2; 4.22 ± 
1.98, 2.5 J/cm2 ) and recove red nearly to normal levels by days 
7- 14 (Fig 4). P ercenL mast cell degra nulation was decreased 
s ignificantly and PUV A dose-dependent ly between 2 h- 3 days 
(15.93 ± 5.78, 1.5 .J/c m2; 9.70 ± 3.31, 2.5 J/cm2 on day 3) as 
compared with t hat in nonirradi ated mice (34.22 ± 9.17) . The 
rate of mast cell degra nulation was resto red from suppression 
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by day 7 in parallel with recovery of ESR (Fig 5) . Mast cell 
numbers/mm were not s ignificantly a ltered by injection with 
Con-A in PUVA-treated groups over a pe riod of 2 h- 14 days 
(5.87- 6.36, 1.5 J/cm2 ; 5 .61- 6.70, 2.5 J/cm2 ) as compared with 
the value in the nonirradiated, Con-A-injected control group 
(6.35 ± 1.00). This value was not different statistically from 
norm a l m ast cell density (see under "PUVA Radiation") . Con-
A-induced ESR, percent mast cell degranulation, or mast cell 
dens ity in treated mice were not remarkably a lte red by either 
irradiation with UV A on ly or a topical application of 8-MOP 
on ly (data not shown in Figs 4 and 5). 
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FIG 4. Con-A-induced ea r sweJ!ing response in PUVA-t.reated mice. 
Ten microliters or Con- A (2.0 mg/ ml) was injected into PUVA-irracli-
ated or nonirradiated (control) mouse ears at several t ime in te rvals 
after a single PUVA irradiation, and ESR. above the baseline t hickness 
was measured. Each group consisted or 5 mice (10 ear samples). Each 
value (mean ± I SD) of treated mice was co mpared with that of rhe 
nonirradiated, Con-A-injected group (the value or cont rols was rhe 
mea n of those obtained over a 14-day period). No significant effects 
were observed with UVA radiat ion only or with 8-MOP paintin g only 
(the data not show n). 
50 
40 
z 
Q 
1- 30 <{ 
_, 
:::> 
z 
<{ 
a: 
(!) 
w 
20 
0 
~ 
10 
0 '--
0 
/ 
• Non - irradiated 
• PUVA- 1.5 J / cm2 
o PUVA- 2.5 J / cm' 
p value 
a < 0.005 
1> < 0.002 
c < O.OOI 
ZHR 7 14 DAYS 
TIME INTERVALS AFTER PUVA RAD IATION 
F IG 5. Con-A -induced mast cell degranulation in PUVA-treated 
mice. Ten microliters of Con-A (2.0 mg/ml) was injected in to PUVA-
irradiated or nonirradiated (control) mouse ears at several time inter-
vals after a single PUVA irradiation and perce nt of degranu!ated cells 
was counted. Each group co nsisted of 5 mice (10 ear samples). Each 
value (mean ± 1 SO) of treated mice was compared with that of the 
nonirradiated, Con-A-injected group (the value of controls was th~ 
mean of those obtained over a 14-day period). No significant effects 
were observed with UVA radiation only or with 8-MOP painting only 
(the data not shown) . 
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14 DAYS 
TIME INTERVALS AFTER PUVA RADIAT ION 
F IG 6. 5- H ydrox:vtryp ta min e plus his lamine- induced ear swellin !{ 
response in P UVA-t rea ted mi ce. Ten mic roli ters of a mixture of 5- HT 
(1.0 mg/ml ) a nd histamin e (50 mM) was injec ted in to P VA- irrad iated 
o r non irrad iated (control) mouse ea rs a t severa l time int ervals a fter a 
s ingle PUVA irrad iation , a nd ESR a bove the base line t hickness was 
measured. Each !{roup cons isted o f 5 mice (10 ear sa mples). Each va lue 
(mean ± 1 SO) of t reated mice was compa red with that of lhe nonir-
radiated, 5- HT p lus histamine-injected group (the va lue of co ntrols 
was the mean o f t hose obtai ned over a 14-day period). 1one of t he 
treatments s ignifi ca ntly affected E ~ R throughout the experime nt a l 
period (data on 8-MOP pa inting on!~' not s hown ). 
Injection with 5-HT/H istam.ine in PUVA -Trea.Led Mice 
ESR (X 10- 2 mm) evoked by injection with 5-HT/ histamine 
was not significant ly suppressed by any of t he treatments with 
a s ingle PUYA radiation (16.83- 18.67, 1.5 J /cm2; 16.50- 18.53, 
2.5 J /cm2 ) , radiation with U YA only, or topical app lication of 
8 -MOP only throughout a pe riod of 2 h- 14 days as compared 
with t hose in nonirradiated mice (17.05 ± 3.36) (Fig 6, data on 
8 -MOP only are not shown). 
DI SCUSSIO N 
T he results of this study demonstrated that pretreatment of 
ea r skin with PUVA radiation s igni ficantly suppressed ESR 
and the rate of mast cell degranulation evoked by compound 
48/80 or Con-A, whi le t he increase in vascula r permeabi lity 
induced by loca l injection with 5-HT / hi stamine was not re-
markably inhibi ted by PUVA t reatment . Tt seems therefore 
t hat suppression in skin reactivity to mast ce ll li berators by 
PUY A may be due to t he effect of PUV A on mast ce ll s t hem-
selves but does not result from an alte red vascu lar response to 
secretory products of mast ce ll s. 
Currently hypothesized mechanisms of action of PUV A at 
the biochem ica l level include in teraction with nuclear DNA 
and oxygen radica l production [1 2]. H owever, in this case none 
of t hose mechanisms could provide an approp riate basis for t he 
PUY A effect on mast cell s because of t he following reasons: A 
single administration of PUV A radiation at a given dose did 
not change at a ll mast ce ll numbers or t heir morphology, eit her 
histologica lly or electron microscopica lly (ou r unpubli shed ob-
servations), suggesting that PUYA does not result in cytolytic 
damage to t hem t hrough harmful oxygen rad ica l production. 
S ince vasoactive am ines are preformed mediato rs stored in 
mast cell secreto ry gra nules (they a re not de novo-synthes ized 
products), and since in t he present study suppression in mast 
ce ll degranulation by PUY A was an early event (it became 
apparent by 2 h postirradiation) , our results cou ld not be 
exp lained by assuming t hat PUYA diminishes mast cell con-
tents by inhibi t ing their synthesis. If the PUVA effect of mast 
cells is a result of suppression both in DNA synthesis and 
subsequent ly occurring metabo lic pathways, its manifestations 
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would be more delayed (a maximum inhibi t ion in DNA synthe-
sis occurs at 6 h postirradiation [13]), a lt hough th is possibility 
could not abso lutely be excluded. The above observations rather 
favo r t he idea t hat PUY A may stab ilize t he mast ce ll mem -
branes involved in degranulation processes. We at present 
consider t he possibili ty t hat PUV A inactivates membrane-
bound and/or intracellula r enzymes t hat participate in mast 
cell degranu lation. Our interpretation appears to be supported 
by t he labo ratory data recen t ly reported by Gendimenico and 
Kochevar [14]. They have found decreased responses of rat 
peri to nea l mast cells to compound 48/80 or chlortetracycline, 
calcium ionophore, by t he treatment of t he cells with UV plus 
photosensitizers (UV A plus acridine or UVB plus benoxapro-
fen). Since th is phenomenon occurred at lower UV doses where 
mast cell degranulation was not detected, t he aut hors have 
cla imed that those photosensit izers may cause noncytolytic 
alterations to mast cell membranes. 
Ear skin responses to mast cell degranu lators were sti ll 
suppressed on days 3- 7 after a s ingle PUVA treatment and 
returned to normal levels by days 7-14, suggesting a retarded 
repa ir of a lterations in mast cell membranes. The prolonged 
suppression is unlikely to be a nonspecific phenomenon caused 
by PUY A inf1ammation because, in t he dose range given, PUV A 
produced neit her measurable ESR nor appreciable cellular in -
filtrates. Alternatively, within this period, damaged mast ce lls 
may be rep laced by in tact, mature mast ce lls t hat differentia te 
from t issue-fixed immature forms and even from precursors of 
bone marrow origin [15]. 
Fjellner and Hagennark [6] have demonstrated that a re-
peated ora l PUYA regimen (8.14 J /cm2 X 8- 12: total 74.6 J j 
em~) admini stered to normal human skin inhibits itch and f1are 
responses to compound 48/80, while histamine-induced skin 
responses a re suppressed only to a minor degree, suggesting 
t hat PUY A may affect mast cell release mechanisms. Kalimo, 
Kou lu , and Jansen [7], however, have argued that PUVA ex-
posure causes a diminished sk in reactivity against histamine 
itse lf but has no effects on cutaneous mast cells because a single 
PUV A radiation with erythemogenic doses was ab le to reduce 
wheal sizes evoked by compound 48/80 or histamine to a similar 
degree. Suppression in skin reactivity to compound 48/ 80 by 
PUY A is a common observation of ours and those two studies, 
while t he data on t he histamine injection appear to be contro-
ve rsia l. However, t he resul ts cou ld not eas ily be compared 
because of different dosages and regimens of PUVA in use. In 
addi t ion, radiatio n with UYB at moderate doses has a lso been 
reported to exert a simila r effect on t he mast ce ll/ histamine 
system [6,7,16]. 
In urticaria pigmentosa, successive se ries of PUV A radiation 
also can relieve itching and whealing [2,3 ,17]. Briffa et al [2] 
found that PUY A did not cause sign ifica n t alterations in mast 
cell numbers or skin histamine contents throughout t heir ob-
se rvatio n period, suggesting t hat PUY A effects may be attrib-
uted to inhibition in the release of histamine from mast cells. 
Our data with mice support t hei r interpretation. However, in 
this hyperproli ferative disorder, inhibit ion of mast ce ll proli f-
eration and maturation by mul tip le PUV A t reatments should 
also be taken into consideration as suggested by Granerus et a l 
!3] and Ko lde, Frosch, and Czarnetzki (17]. T he latter aut hors 
have recently shown a decrease in mast ce ll numbers in the 
subepidermal space with lowered histamine leve ls in PUYA-
treated lesions of urt icar ia pigmentosa. Ult rastructural findinrrs 
suggest that leakage of granule mediators with a suppress;d 
resynthesis due to t he PUVA effect may exp lain in part t he 
underlying mechan isms of the phot.ochemotherapy in t hi s dis-
ease. 
Finally, it is conceivable that PUY A suppresses t he ini tial 
phase of immediate-type hypersensitivity reactions, probably 
t hrough interference with t he mast cell / histamine system. This 
suggestion, however, must be confirmed by further studies using 
lgE because compound 48/80 and Con-A are only nonimmu-
nologic liberators. 
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